Synergy Asset Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,686
Closed -$269K 584
2024
Q4
$269K Buy
+2,686
New +$286K 0.02% 178
2024
Q3
Sell
-19,905
Closed -$2.12M 165
2024
Q2
$2.12M Sell
19,905
-6,650
-25% -$668K 0.33% 68
2024
Q1
$2.57M Sell
26,555
-4,274
-14% -$438K 0.44% 65
2023
Q4
$3.11M Sell
30,829
-3,353
-10% -$324K 0.56% 53
2023
Q3
$3.48M Buy
34,182
+8,238
+32% +$836K 0.69% 40
2023
Q2
$2.62M Buy
+25,944
New +$2.59M 0.65% 47

Other funds holding NVS

Synergy Asset Management's NVS Position: Q1 2025 in Review

Synergy Asset Management sold out of Novartis (NVS) in Q1 2025, closing a stake of 2,686 shares — an estimated $269K sold.

Synergy Asset Management first reported a position in NVS in Q2 2023 and held it in 6 quarters. The position peaked at $3.48M in Q3 2023. 1,356 funds tracked by Wall St. Rank hold NVS as of Q1 2025.

  • Synergy Asset Management reported no remaining Novartis position as of Q1 2025 after selling out during the quarter.
  • Synergy Asset Management sold 2,686 Novartis shares in Q1 2025, an estimated $269K.
  • Synergy Asset Management first reported a position in Novartis in Q2 2023 and held it in 6 quarters.
  • Synergy Asset Management's Novartis position peaked at $3.48M in Q3 2023.
  • 1,356 funds tracked by Wall St. Rank held Novartis as of Q1 2025.

Based on Synergy Asset Management's 13F filing for Q1 2025, filed 22 Apr 2025.